Biotech · Private company
Wyeth is now a wholly owned subsidiary of Pfizer
Track this companyFree. Adds Wyeth is now a wholly owned subsidiary of Pfizer to your Dealase workspace and tells you when its record changes.
Clinical trials250 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- Desvenlafaxine succinate sustained-release (DVS SR)Phase 3 · DepressionClinicalTrials.gov · fetched Nov 12, 2026
- EscitalopramPhase 3 · DepressionClinicalTrials.gov · fetched Nov 12, 2026
- pantoprazole sodium enteric-coated spheroidPhase 3 · Gastroesophageal RefluxClinicalTrials.gov · fetched Nov 12, 2026
- Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)Phase 2 · Depressive Disorder, Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
- DonepezilPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Double-blind investigational anti-arrhythmicPhase 2 · ArrhythmiasClinicalTrials.gov · fetched Nov 12, 2026
- GAP-486Phase 2 · ArrhythmiasClinicalTrials.gov · fetched Nov 12, 2026
- lecozotan SRPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Methotrexate plus ERB-041 for 12 weeksPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- ILV-094Phase 1 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- NSA-789Phase 1 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- NSA-789Phase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- NSA-789 at 2 different dosesPhase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
- TRU-015Phase 1 · Lymphoma, B-CellClinicalTrials.gov · fetched Nov 12, 2026
- ampicillin-sulbactamSkin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- ERB-041Cystitis, InterstitialClinicalTrials.gov · fetched Nov 12, 2026
- TigecyclineSkin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)PHASE2 · COMPLETED · started Jun 4, 2010ClinicalTrials.gov NCT01134575 · fetched Nov 12, 2026
- Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective DisorderPHASE1 · WITHDRAWN · started May 1, 2009ClinicalTrials.gov NCT00892021 · fetched Nov 12, 2026
- Tacrolimus to Sirolimus Conversion for Delayed Graft FunctionPHASE4 · TERMINATED · started Apr 1, 2009ClinicalTrials.gov NCT00931255 · fetched Nov 12, 2026
- Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic PatientsPHASE1 · WITHDRAWN · started Jan 1, 2009ClinicalTrials.gov NCT00781794 · fetched Nov 12, 2026
- Temsirolimus for Relapsed/Refractory Hodgkin's LymphomaPHASE2 · TERMINATED · started Jan 1, 2009ClinicalTrials.gov NCT00838955 · fetched Nov 12, 2026
- Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789PHASE1 · COMPLETED · started Jan 1, 2009ClinicalTrials.gov NCT00795730 · fetched Nov 12, 2026
- Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive DisorderPHASE2 · COMPLETED · started May 1, 2008ClinicalTrials.gov NCT00669110 · fetched Nov 12, 2026
- Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With PsoriasisPHASE1 · COMPLETED · started Dec 20, 2007ClinicalTrials.gov NCT00563524 · fetched Nov 12, 2026
- Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal CancerPHASE1 · COMPLETED · started Nov 1, 2007ClinicalTrials.gov NCT00593060 · fetched Nov 12, 2026
- Study Evaluating TRU-015 in B-Cell Non-Hodgkin's LymphomaPHASE1 · TERMINATED · started Sep 1, 2007ClinicalTrials.gov NCT00521638 · fetched Nov 12, 2026
- Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenPHASE3 · COMPLETED · started Dec 1, 2006ClinicalTrials.gov NCT00406640 · fetched Nov 12, 2026
- Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)PHASE3 · COMPLETED · started Oct 31, 2006ClinicalTrials.gov NCT00401375 · fetched Nov 12, 2026
- Evaluation of Airway Gene Expression in COPD and Controlled PopulationsTERMINATED · started Sep 1, 2006ClinicalTrials.gov NCT00571792 · fetched Nov 12, 2026
- Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin InfectionsPHASE4 · COMPLETED · started Sep 1, 2006ClinicalTrials.gov NCT00368537 · fetched Nov 12, 2026
- Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial CystitisNA · WITHDRAWN · started Aug 1, 2006ClinicalTrials.gov NCT00275379 · fetched Nov 12, 2026
- Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)PHASE3 · COMPLETED · started May 1, 2006ClinicalTrials.gov NCT00300755 · fetched Nov 12, 2026
- RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMASPHASE2 · COMPLETED · started Dec 20, 2005ClinicalTrials.gov NCT00126672 · fetched Nov 12, 2026
- Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)PHASE2 · COMPLETED · started Oct 6, 2005ClinicalTrials.gov NCT00151398 · fetched Nov 12, 2026
- Study Evaluating ERB-041 With Methotrexate in Rheumatoid ArthritisPHASE2 · COMPLETED · started Aug 1, 2005ClinicalTrials.gov NCT00141830 · fetched Nov 12, 2026
- Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of DepressionPHASE4 · COMPLETED · started Aug 1, 2005ClinicalTrials.gov NCT00200902 · fetched Nov 12, 2026
- Study Evaluating GAP-486 in Non-sustained Ventricular TachycardiaPHASE2 · TERMINATED · started Jun 1, 2005ClinicalTrials.gov NCT00124891 · fetched Nov 12, 2026
- Study of Methylnaltrexone (MNTX) for the Relief of ConstipationPHASE3 · COMPLETED · started Feb 1, 2004ClinicalTrials.gov NCT00402038 · fetched Nov 12, 2026
- Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)PHASE2 · COMPLETED · started Sep 1, 2001ClinicalTrials.gov NCT00192387 · fetched Nov 12, 2026
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and OlderPHASE2 · COMPLETED · started Jul 1, 2001ClinicalTrials.gov NCT00192153 · fetched Nov 12, 2026
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy AdultsPHASE3 · COMPLETED · started Nov 1, 2000ClinicalTrials.gov NCT00192192 · fetched Nov 12, 2026